379 related articles for article (PubMed ID: 34986238)
1. Vasculopathy in COVID-19.
Flaumenhaft R; Enjyoji K; Schmaier AA
Blood; 2022 Jul; 140(3):222-235. PubMed ID: 34986238
[TBL] [Abstract][Full Text] [Related]
2. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
3. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
[TBL] [Abstract][Full Text] [Related]
4. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
5. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
6. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
7. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
Seltzer S
Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 - A vascular disease.
Siddiqi HK; Libby P; Ridker PM
Trends Cardiovasc Med; 2021 Jan; 31(1):1-5. PubMed ID: 33068723
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
Zhang J; Tecson KM; McCullough PA
Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
[TBL] [Abstract][Full Text] [Related]
10. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
[TBL] [Abstract][Full Text] [Related]
12. Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation.
Lu RXZ; Lai BFL; Rafatian N; Gustafson D; Campbell SB; Banerjee A; Kozak R; Mossman K; Mubareka S; Howe KL; Fish JE; Radisic M
Lab Chip; 2022 Mar; 22(6):1171-1186. PubMed ID: 35142777
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.
Joffre J; Rodriguez L; Matthay ZA; Lloyd E; Fields AT; Bainton RJ; Kurien P; Sil A; Calfee CS; Woodruff PG; Erle DJ; Hendrickson C; Krummel MF; Langelier CR; Matthay MA; Kornblith LZ; Hellman J; ;
Am J Respir Crit Care Med; 2022 Oct; 206(8):961-972. PubMed ID: 35649173
[No Abstract] [Full Text] [Related]
14. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
15. The Role of Endothelium in COVID-19.
Ionescu M; Stoian AP; Rizzo M; Serban D; Nuzzo D; Mazilu L; Suceveanu AI; Dascalu AM; Parepa IR
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769350
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate.
Yang K; Holt M; Fan M; Lam V; Yang Y; Ha T; Williams DL; Li C; Wang X
Front Immunol; 2022; 13():868679. PubMed ID: 35401579
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
Xu SW; Ilyas I; Weng JP
Acta Pharmacol Sin; 2023 Apr; 44(4):695-709. PubMed ID: 36253560
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.
Higashikuni Y; Liu W; Obana T; Sata M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769508
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.
Gustafson D; Ngai M; Wu R; Hou H; Schoffel AC; Erice C; Mandla S; Billia F; Wilson MD; Radisic M; Fan E; Trahtemberg U; Baker A; McIntosh C; Fan CS; Dos Santos CC; Kain KC; Hanneman K; Thavendiranathan P; Fish JE; Howe KL
EBioMedicine; 2022 Apr; 78():103982. PubMed ID: 35405523
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.
Rodríguez C; Luque N; Blanco I; Sebastian L; Barberà JA; Peinado VI; Tura-Ceide O
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):407-415. PubMed ID: 33180562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]